Oramed Pharmaceuticals Inc.

ORMP
$4.84 (+ $0.20 + 4.31%)
Last updated: 2026-06-30 18:31 UTC
ORMP Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS68403P2039
CUSIP68403P203
Market Price4.84
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyAnnually
P/E Ratio3.15
EPS1.0
Market Cap$125.5M
Book Value4.98
Price to Book0.633
Beta1.17
52w High3.23
52w Low1.82
Next Earnings DateN/A

Oramed Pharmaceuticals Inc. trades under ticker ORMP on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US68403P2039, CUSIP 68403P203.

About the Company
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Price History